# Efficacy of Nonsteroidal Anti-Inflammatory Drugs for the Prevention of Cystoid Macular Edema Following Cataract Phacoemulsification

> **NCT07696104** · PHASE4 · COMPLETED · sponsor: **Pomeranian Medical University Szczecin** · enrollment: 88 (actual)

## Conditions studied

- Pseudophakic Cystoid Macular Edema

## Interventions

- **DRUG:** Bromfenac 0.09 % Ophthalmic Solution
- **DRUG:** Bromfenac 0.09 % Ophthalmic Solution
- **DRUG:** Nepafenac 0.1% eyedrops
- **DRUG:** diclofenac 0.1% ophthalmic susp.

## Key facts

- **NCT ID:** NCT07696104
- **Lead sponsor:** Pomeranian Medical University Szczecin
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-14
- **Primary completion:** 2024-05-22
- **Final completion:** 2024-05-22
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2026-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07696104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07696104, "Efficacy of Nonsteroidal Anti-Inflammatory Drugs for the Prevention of Cystoid Macular Edema Following Cataract Phacoemulsification". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07696104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*